Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
DMARD
How do you handle medication refills for patients on traditional DMARDs who are lost to follow-up?
Related Questions
How do you approach the use of immunosuppressive therapy in patients with rheumatoid arthritis and underlying immunodeficiency, such as IgA deficiency?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
Are there specific combinations of DMARDs and/or biologics that you avoid due to elevated infection risk or other safety concerns?
When trying to increase infliximab for active disease (inflammatory arthritis or sarcoidosis), do you prefer to increase dosage or reduce frequency between doses?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
How do you approach management of a patient with multiple lung nodules and low titer +CCP but no active joint symptoms suggestive of RA?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
How do you approach diagnosis in a patient with inflammatory joint symptoms and isolated bilateral CMC joint erosions on x-ray imaging?
